[1] |
Léauté⁃Labrèze C, Harper JI, Hoeger PH. Infantile haemangioma[J]. Lancet, 2017,390(10089):85⁃94. doi: 10.1016/S0140⁃6736(16)00645⁃0.
|
[2] |
Krowchuk DP, Frieden IJ, Mancini AJ, et al. Clinical practice guideline for the management of infantile hemangiomas[J]. Pediatrics, 2019,143(1):e20183475. doi: 10.1542/peds.2018⁃3475.
|
[3] |
Greenberger S, Bischoff J. Pathogenesis of infantile haemangioma[J]. Br J Dermatol, 2013,169(1):12⁃19. doi: 10. 1111/bjd.12435.
|
[4] |
Yu B, Wang S. Angio⁃LncRs: LncRNAs that regulate angiogenesis and vascular disease[J]. Theranostics, 2018,8(13):3654⁃3675. doi: 10.7150/thno.26024.
|
[5] |
Darrow DH, Greene AK, Mancini AJ, et al. Diagnosis and management of infantile hemangioma[J]. Pediatrics, 2015, 136(4):e1060⁃e1104. doi: 10.1542/peds.2015⁃2485.
|
[6] |
杨开颖, 陈思源, 吉毅. 婴儿血管瘤发病过程中的关键信号通路[J]. 国际皮肤性病学杂志, 2017,43(6):369⁃373. doi: 10. 3760/cma.j.issn.1673⁃4173.2017.06.014.
|
[7] |
Fatica A, Bozzoni I. Long non⁃coding RNAs: new players in cell differentiation and development[J]. Nat Rev Genet, 2014,15(1):7⁃21. doi: 10.1038/nrg3606.
|
[8] |
Kumar MM, Goyal R. LncRNA as a therapeutic target for angiogenesis[J]. Curr Top Med Chem, 2017,17(15):1750⁃1757. doi: 10.2174/1568026617666161116144744.
|
[9] |
Palmieri D, Bouadis A, Ronchetti R, et al. Rab11a differentially modulates epidermal growth factor⁃induced proliferation and motility in immortal breast cells[J]. Breast Cancer Res Treat, 2006,100(2):127⁃137. doi: 10.1007/s10549⁃006⁃9244⁃6.
|
[10] |
Ji Y, Chen S, Li K, et al. Signaling pathways in the development of infantile hemangioma[J]. J Hematol Oncol, 2014,7:13. doi: 10.1186/1756⁃8722⁃7⁃13.
|
[11] |
Ji Y, Chen S, Xiang B, et al. Jagged1/Notch3 signaling modulates hemangioma⁃derived pericyte proliferation and maturation[J]. Cell Physiol Biochem, 2016,40(5):895⁃907. doi: 10.1159/000453148.
|
[12] |
Fang H, Jin J, Huang D, et al. PAI⁃1 induces Src inhibitor resistance via CCL5 in HER2⁃positive breast cancer cells[J]. Cancer Sci, 2018,109(6):1949⁃1957. doi: 10.1111/cas.13593.
|
[13] |
Yu XM, Jaskula⁃Sztul R, Georgen MR, et al. Notch1 signaling regulates the aggressiveness of differentiated thyroid cancer and inhibits SERPINE1 expression[J]. Clin Cancer Res, 2016,22(14):3582⁃3592. doi: 10.1158/1078⁃0432.CCR⁃15⁃1749.
|
[14] |
Ichikawa⁃Shindo Y, Sakurai T, Kamiyoshi A, et al. The GPCR modulator protein RAMP2 is essential for angiogenesis and vascular integrity[J]. J Clin Invest, 2008,118(1):29⁃39. doi: 10. 1172/JCI33022.
|
[15] |
Park H, Park H, Chung HY, et al. Comparative analysis of the extracellular matrix composition in proliferating and involuted infantile hemangiomas[J]. Arch Plast Surg, 2015,42(5):544⁃551. doi: 10.5999/aps.2015.42.5.544.
|
[16] |
Storch CH, Hoeger PH. Propranolol for infantile haemangiomas: insights into the molecular mechanisms of action[J]. Br J Dermatol, 2010,163(2):269⁃274. doi: 10.1111/j.1365⁃2133.2010. 09848.x.
|
[17] |
Remiker AS, Palumbo JS. Mechanisms coupling thrombin to metastasis and tumorigenesis[J]. Thromb Res, 2018,164 Suppl 1:S29⁃S33. doi: 10.1016/j.thromres.2017.12.020.
|
[18] |
Heldin CH, Lennartsson J, Westermark B. Involvement of platelet⁃derived growth factor ligands and receptors in tumorigenesis[J]. J Intern Med, 2018,283(1):16⁃44. doi: 10. 1111/joim.12690.
|
[19] |
Anderson M, Marayati R, Moffitt R, et al. Hexokinase 2 promotes tumor growth and metastasis by regulating lactate production in pancreatic cancer[J]. Oncotarget, 2017,8(34):56081⁃56094. doi: 10.18632/oncotarget.9760.
|
[20] |
Zhuo B, Li Y, Li Z, et al. PI3K/Akt signaling mediated Hexokinase⁃2 expression inhibits cell apoptosis and promotes tumor growth in pediatric osteosarcoma[J]. Biochem Biophys Res Commun, 2015,464(2):401⁃406. doi: 10.1016/j.bbrc.2015. 06.092.
|